Published in Pain on May 09, 2007
Motivational Interviewing to Reduce Substance Use Among Depression Patients | NCT02420561
Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy | NCT00988962
Mobile Application for Prescription Drug-Abuse Education (MAPDE) (MAPDE) | NCT03165175
Pre-op Cognitive Behavior Therapy to Decrease Chronic Post-Surgical Pain in TKA | NCT04814992
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36
Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain (2008) 1.98
Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain (2010) 1.97
American Society for Pain Management nursing position statement: pain management in patients with substance use disorders. Pain Manag Nurs (2012) 1.43
Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med (2012) 1.35
Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32
Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol (2014) 1.25
A research agenda for enhancing appropriate opioid prescribing in primary care. J Gen Intern Med (2013) 1.23
Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain (2010) 1.18
The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev (2013) 1.14
Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). J Addict Med (2009) 1.13
Characteristics of older adults receiving opioids in primary care: treatment duration and outcomes. Pain Med (2010) 1.13
Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain (2010) 1.11
A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc (2009) 1.10
Primary care providers’ judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. J Gen Intern Med (2011) 1.07
Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry (2012) 1.06
Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend (2009) 1.00
Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J Pain Symptom Manage (2011) 1.00
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain (2012) 0.99
Strategies to reduce the tampering and subsequent abuse of long-acting opioids: potential risks and benefits of formulations with physical or pharmacologic deterrents to tampering. Mayo Clin Proc (2012) 0.98
Mindfulness-oriented recovery enhancement ameliorates the impact of pain on self-reported psychological and physical function among opioid-using chronic pain patients. J Pain Symptom Manage (2014) 0.97
Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend (2012) 0.96
Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Res Treat (2011) 0.95
Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage (2008) 0.95
Prescription use disorders in older adults. Am J Addict (2010) 0.93
Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity. Psychopharmacology (Berl) (2014) 0.93
Pilot of a brief, web-based educational intervention targeting safe storage and disposal of prescription opioids. Addict Behav (2013) 0.92
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol. J Opioid Manag (2012) 0.90
Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics. Prim Care (2011) 0.87
The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving. J Pain (2013) 0.87
Associations among pain, non-medical prescription opioid use, and drug overdose history. Am J Addict (2013) 0.87
Laboratory testing for prescription opioids. J Med Toxicol (2012) 0.86
Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addict Behav (2012) 0.86
Improving opioid prescription practices and reducing patient risk in the primary care setting. J Pain Res (2014) 0.85
Measuring pain medication expectancies in adults treated for substance use disorders. Drug Alcohol Depend (2010) 0.85
Aberrant drug-related behaviors: unsystematic documentation does not identify prescription drug use disorder. Pain Med (2012) 0.85
Integrating pain management in clinical practice. J Clin Psychol Med Settings (2012) 0.84
Attentional bias for prescription opioid cues among opioid dependent chronic pain patients. J Behav Med (2012) 0.84
Managing pain in high-risk patients within a patient-centered medical home. Transl Behav Med (2012) 0.83
Allostatic dysregulation of natural reward processing in prescription opioid misuse: autonomic and attentional evidence. Biol Psychol (2015) 0.83
How Frequently are "Classic" Drug-Seeking Behaviors Used by Drug-Seeking Patients in the Emergency Department? West J Emerg Med (2012) 0.83
A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res (2015) 0.82
Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic pain. Addict Behav (2013) 0.82
Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain (2013) 0.82
Shortening the Current Opioid Misuse Measure via computer-based testing: a retrospective proof-of-concept study. BMC Med Res Methodol (2013) 0.82
The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. Clin J Pain (2014) 0.81
Patients as collaborators: using focus groups and feedback sessions to develop an interactive, web-based self-management intervention for chronic pain. Pain Med (2013) 0.81
Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review. Subst Abus (2015) 0.81
Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain. Anesthesiology (2015) 0.80
The Canary in the Coal Mine Tweets: Social Media Reveals Public Perceptions of Non-Medical Use of Opioids. PLoS One (2015) 0.79
Screening for addictive disorders within a workers' compensation clinic: an exploratory study. Subst Use Misuse (2011) 0.79
Comparing chronic pain treatment seekers in primary care versus tertiary care settings. J Am Board Fam Med (2014) 0.79
How do emergency physicians interpret prescription narcotic history when assessing patients presenting to the emergency department with pain? Perm J (2012) 0.78
Mitigating the risk of opioid abuse through a balanced undergraduate pain medicine curriculum. J Pain Res (2013) 0.78
Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain. J Pain (2016) 0.78
Factors Associated with Opioid Use in a Cohort of Patients Presenting for Surgery. Pain Res Treat (2015) 0.77
Validation of a brief Opioid Compliance Checklist for patients with chronic pain. J Pain (2014) 0.77
Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing. Pain Med (2015) 0.77
Narcotic analgesic utilization amongst injured workers: using concept mapping to understand current issues from the perspectives of physicians and pharmacists. BMC Health Serv Res (2011) 0.77
Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards. Psychother Psychosom (2017) 0.77
Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect. Pain Med (2016) 0.76
Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients. Drug Alcohol Depend (2014) 0.76
Use of prescription pain medications among medical cannabis patients: comparisons of pain levels, functioning, and patterns of alcohol and other drug use. J Stud Alcohol Drugs (2015) 0.76
Development of an Opioid-Related Overdose Risk Behavior Scale (ORBS). Subst Abus (2017) 0.76
Computerized progress notes for chronic pain patients receiving opioids; the Prescription Opioid Documentation System (PODS). Pain Med (2010) 0.75
Case Presentations from the Addiction Academy. J Med Toxicol (2016) 0.75
Pain Assessment-Can it be Done with a Computerised System? A Systematic Review and Meta-Analysis. Int J Environ Res Public Health (2016) 0.75
Potential for tramadol abuse by patients visiting pharmacies in northern iran. Subst Abuse (2011) 0.75
Differences in the Association between Depression and Opioid Misuse in Chronic Low Back Pain versus Chronic Pain at Other Locations. Healthcare (Basel) (2016) 0.75
Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease. Am J Prev Med (2016) 0.75
American Society for Pain Management nursing position statement: pain management in patients with substance use disorders. J Addict Nurs (2012) 0.75
Treating pain in addicted patients: recommendations from an expert panel. Popul Health Manag (2013) 0.75
Translation and validation of the Chinese version of the Current Opioid Misuse Measure (COMM) for patients with chronic pain in Mainland China. Health Qual Life Outcomes (2015) 0.75
Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication. Pain (2016) 0.75
Obstacles to the Prescription and Use of Opioids. Prim Care Companion CNS Disord (2016) 0.75
Evaluation of the current opioid misuse measure among substance use disorder treatment patients. J Subst Abuse Treat (2015) 0.75
Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse. Psychopharmacology (Berl) (2016) 0.75
Opioid-Involved Overdose Among Male Afghanistan/Iraq-Era U.S. Military Veterans: A Multidimensional Perspective. Subst Use Misuse (2017) 0.75
Sample size and optimal designs for reliability studies. Stat Med (1998) 6.80
Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess (2003) 4.88
Trends in medical use and abuse of opioid analgesics. JAMA (2000) 4.23
A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage (2004) 3.99
Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain (1997) 2.58
Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage (2004) 2.58
Being inconsistent about consistency: when coefficient alpha does and doesn't matter. J Pers Assess (2003) 2.33
Validation of a screener and opioid assessment measure for patients with chronic pain. Pain (2004) 2.22
Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain (2007) 2.18
Sample size determination for diagnostic accuracy studies involving binormal ROC curve indices. Stat Med (1997) 2.08
Treating pain patients at risk: evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med (2003) 2.03
Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage (1998) 1.97
Using concept mapping to develop a conceptual framework of staff's views of a supported employment program for individuals with severe mental illness. J Consult Clin Psychol (1994) 1.88
Assessment for addiction in pain-treatment settings. Clin J Pain (2002) 1.61
Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain (2007) 1.56
Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manage (2004) 1.55
Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage (2006) 1.40
A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther (2004) 1.40
Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain (2002) 1.18
The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain. Pain Med (2003) 1.09
Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain (2002) 1.05
Screening for problematic prescription opioid use. Clin J Pain (2001) 1.03
Physicians advised on how to offer pain relief while preventing opioid abuse. JAMA (2004) 0.90
Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage (2004) 2.58
Validation of a screener and opioid assessment measure for patients with chronic pain. Pain (2004) 2.22
Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain (2007) 2.18
Spanish translation and linguistic validation of the screener and opioid assessment for patients with pain-revised (SOAPP-R). Pain Med (2013) 2.00
Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain (2008) 1.98
Prevalence of HIV among those 15 and older in rural South Africa. AIDS Care (2013) 1.84
Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse? CNS Drugs (2010) 1.70
Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend (2009) 1.63
Foundations of opioid risk management. Clin J Pain (2007) 1.60
Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain (2007) 1.56
Knowledge, attitudes, and practices of US practitioners who provide pre-travel advice. J Travel Med (2014) 1.48
Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm (2005) 1.45
Prevalence of dengue virus infection in US travelers who have lived in or traveled to dengue-endemic countries. J Travel Med (2013) 1.43
Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manage (2006) 1.40
Iatrogenic addiction in patients treated for acute or subacute pain: a systematic review. J Opioid Manag (2007) 1.37
Pretreatment psychosocial variables as predictors of outcomes following lumbar surgery and spinal cord stimulation: a systematic review and literature synthesis. Pain Med (2009) 1.35
Dealing with difficult patients in your pain practice. Reg Anesth Pain Med (2005) 1.32
Abuse risks and routes of administration of different prescription opioid compounds and formulations. Harm Reduct J (2011) 1.28
Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain (2009) 1.27
National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol Drug Saf (2008) 1.27
Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. J Pain (2007) 1.26
Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain (2010) 1.18
Assessment of efficacy of long-term opioid therapy in pain patients with substance abuse potential. Clin J Pain (2002) 1.18
Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. PLoS One (2011) 1.16
Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R). J Addict Med (2009) 1.13
Gender differences in risk factors for aberrant prescription opioid use. J Pain (2009) 1.13
Electronic diaries as a tool to improve pain management: is there any evidence? Pain Med (2007) 1.10
Young children's probability of dying before and after their mother's death: a rural South African population-based surveillance study. PLoS Med (2013) 1.08
Association of anxiety and depression with reported disease severity in patients undergoing evaluation for chronic rhinosinusitis. Ann Otol Rhinol Laryngol (2007) 1.07
Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J (2006) 1.07
Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. Pain Med (2008) 1.06
Measuring attractiveness for abuse of prescription opioids. Pain Med (2009) 1.05
Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postings. Clin J Pain (2007) 1.04
Psychopathology predicts the outcome of medial branch blocks with corticosteroid for chronic axial low back or cervical pain: a prospective cohort study. BMC Musculoskelet Disord (2009) 1.02
Internet-based survey of nonmedical prescription opioid use in the United States. Clin J Pain (2008) 1.01
Associations between daily chronic pain intensity, daily anger expression, and trait anger expressiveness: an ecological momentary assessment study. Pain (2012) 1.00
The impacts of maternal mortality and cause of death on children's risk of dying in rural South Africa: evidence from a population based surveillance study (1992-2013). Reprod Health (2015) 0.99
Alteration in pain modulation in women with persistent pain after lumpectomy: influence of catastrophizing. J Pain Symptom Manage (2012) 0.99
Elevated pain sensitivity in chronic pain patients at risk for opioid misuse. J Pain (2011) 0.98
Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage (2004) 0.96
Characteristics of prescription opioid abusers in treatment: prescription opioid use history, age, use patterns, and functional severity. J Opioid Manag (2010) 0.95
Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. J Pain (2012) 0.93
Food, mood, and attitude: reducing risk for eating disorders in college women. Health Psychol (2005) 0.92
Computer assessment and diagnostic classification of chronic pain patients. Pain Med (2007) 0.90
Measuring online endorsement of prescription opioids abuse: an integrative methodology. Pharmacoepidemiol Drug Saf (2012) 0.89
The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature. Pain Med (2009) 0.89
The association between psychopathology and placebo analgesia in patients with discogenic low back pain. Pain Med (2006) 0.88
Acute low back pain is marked by variability: An internet-based pilot study. BMC Musculoskelet Disord (2011) 0.88
Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction. Appl Health Econ Health Policy (2009) 0.87
Validation of the Spanish Addiction Severity Index Multimedia Version (S-ASI-MV). Drug Alcohol Depend (2008) 0.87
Attitudes of Primary Care Practitioners in Managing Chronic Pain Patients Prescribed Opioids for Pain: A Prospective Longitudinal Controlled Trial. Pain Med (2016) 0.86
Electronic pain assessment in clinical practice. Pain Manag (2011) 0.85
A pilot study of an online workplace nutrition program: the value of participant input in program development. J Nutr Educ Behav (2008) 0.84
Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag (2012) 0.83
Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol (2008) 0.83
Ultrasound-enabled topical anesthesia for pain reduction of phlebotomy for whole blood donation. Transfusion (2008) 0.82
The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain. Clin J Pain (2014) 0.81
In-clinic use of electronic pain diaries: barriers of implementation among pain physicians. J Pain Symptom Manage (2010) 0.81
Distraction analgesia in chronic pain patients: the impact of catastrophizing. Anesthesiology (2014) 0.81
The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis. Pain Med (2014) 0.80
Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine. Pain Med (2007) 0.80
Estimating attractiveness for abuse of a not-yet-marketed "abuse-deterrent" prescription opioid formulation. Pain Med (2009) 0.80
Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use? Expert Opin Drug Deliv (2012) 0.80
Psychiatric Comorbidity Is Associated Prospectively with Diminished Opioid Analgesia and Increased Opioid Misuse in Patients with Chronic Low Back Pain. Anesthesiology (2015) 0.80
Working it out: development and testing of a multimedia, vocational education program. Subst Use Misuse (2004) 0.80
Preliminary development of a responder index for chronic low back pain. J Rheumatol (2007) 0.79
Efficacy and safety of tanezumab in the treatment of pain from bone metastases. Pain (2015) 0.79
National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes. Pain (2015) 0.79
International travel by persons with medical comorbidities: understanding risks and providing advice. Mayo Clin Proc (2013) 0.79
Opioid medication management: clinician beware! Anesthesiology (2010) 0.78
Self-reports of medication side effects and pain-related activity interference in patients with chronic pain: a longitudinal cohort study. Pain (2015) 0.78
Opioids for neuropathic pain. Curr Pain Headache Rep (2005) 0.78
Development of a bedside pain assessment kit for the classification of patients with osteoarthritis. Rheumatol Int (2014) 0.77
Computer-mediated addiction services: tomorrow won't look like today. Behav Healthc Tomorrow (2002) 0.77
Further qualification of a therapeutic responder index for patients with chronic low back pain. J Rheumatol (2010) 0.77
Innovative delivery of pain management interventions: current trends and future progress. Clin J Pain (2015) 0.77